Science Explorer Back to mapMap

Most cited papers from Memorial Healthcare System

What are the most cited papers from Memorial Healthcare System?

The most cited paper from Memorial Healthcare System is "Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer" (José Baselga et al., 2011), with 2,868 citations. Next come "Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography" (849) and "Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC" (677).

Showing 50 of 60 papers. Every paper with more than 51 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Everolimus in Postmenopausal Hormone-Receptor–Positive Advanced Breast Cancer José Baselga et al. · New England Journal of Medicine Open access 7 Dec 2011 2,868
2 Breast Cancer Screening Using Tomosynthesis in Combination With Digital Mammography Sarah M. Friedewald, Elizabeth A. Rafferty, Stephen L. Rose et al. · JAMA 24 Jun 2014 849
3 Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC Christian Diego Rolfo et al. · Journal of Thoracic Oncology Open access 6 Jun 2018 677
4 Association of Circulating Tumor DNA and Circulating Tumor Cells After Neoadjuvant Chemotherapy With Disease Recurrence in Patients With Triple-Negative Breast Cancer Milan Radovich et al. · JAMA Oncology Open access 9 Jul 2020 313
5 Integrative Oncology Care of Symptoms of Anxiety and Depression in Adults With Cancer: Society for Integrative Oncology–ASCO Guideline Linda Ellen Carlson, Nofisat Ismaila, Elizabeth L. Addington et al. · Journal of Clinical Oncology Open access 15 Aug 2023 303
6 Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) Míkel Izquierdo et al. · The journal of nutrition health & aging Open access 31 Dec 2024 250
7 Comparison of Video-Assisted Thoracoscopic Surgery and Robotic Approaches for Clinical Stage I and Stage II Non-Small Cell Lung Cancer Using The Society of Thoracic Surgeons Database Brian E. Louie, Jennifer L. Wilson, Sunghee Kim et al. · The Annals of Thoracic Surgery Open access 20 May 2016 243
8 Characterization of KRAS Mutation Subtypes in Non–small Cell Lung Cancer Julia Judd et al. · Molecular Cancer Therapeutics Open access 13 Sep 2021 197
9 Lapatinib plus Letrozole as First-Line Therapy for HER-2+ Hormone Receptor–Positive Metastatic Breast Cancer Lee Steven Schwartzberg, Sandra Franco, Allison M. Florance et al. · The Oncologist Open access Feb 2010 191
10 Update on Preoperative Breast Localization Mary Katherine Hayes · Radiologic Clinics of North America 17 Apr 2017 187
11 Putting Medical Boots on the Ground: Lessons from the War in Ukraine and Applications for Future Conflict with Near-Peer Adversaries Aaron Epstein, Robert B. Lim, Jay A. Johannigman et al. · Journal of the American College of Surgeons Open access 24 Apr 2023 166
12 Entrectinib: a potent new TRK, ROS1, and ALK inhibitor Christian Diego Rolfo, Rossana Ruiz, Elisa Giovannetti et al. · Expert Opinion on Investigational Drugs Open access 12 Oct 2015 155
13 E-learning in graduate medical education: survey of residency program directors Christopher M. Wittich, Anoop Agrawal, David A. Cook et al. · BMC Medical Education Open access 11 Jul 2017 128
14 Folate Receptor Alpha—A Novel Approach to Cancer Therapy Teresita Pérez González, Meri Muminovic, Olger Nano et al. · International Journal of Molecular Sciences Open access 15 Jan 2024 121
15 Vocal Tract Resonance Analysis of Aging Voice Using Long-Term Average Spectra Sue Ellen Linville, Jennifer Rens · Journal of Voice Sep 2001 119
16 Liquid Biopsy Versus Tissue Biopsy to Determine Front Line Therapy in Metastatic Non-Small Cell Lung Cancer (NSCLC) Luis Estuardo Raez, Kayla Brice, Katerine Dumais et al. · Clinical Lung Cancer 25 Nov 2022 114
17 Long-Term Effects of COVID-19 Shreeya R. Joshee, Nikhil Vatti, Christopher Chia-Chi Chang · Mayo Clinic Proceedings Open access 11 Jan 2022 114
18 York platelet syndrome is a CRAC channelopathy due to gain-of-function mutations in STIM1 Thomas C. Markello et al. · Molecular Genetics and Metabolism Open access 23 Dec 2014 112
19 Preventing medication errors with smart infusion technology Karen Wilson, Mark Sullivan · American Journal of Health-System Pharmacy 15 Jan 2004 112
20 Prognostic Value of Nonischemic Ringlike Left Ventricular Scar in Patients With Apparently Idiopathic Nonsustained Ventricular Arrhythmias Daniele Muser et al. · Circulation Open access 6 Jan 2021 107
21 Patterns of ED use and perceptions of the elderly regarding their emergency care: A synthesis of recent research Carol Lynne Grief · Journal of Emergency Nursing Apr 2003 100
22 IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production Alena Cristina Jaime‐Ramirez, Bethany L. Mundy-Bosse, SriVidya Kondadasula et al. · The Journal of Immunology Open access 15 Feb 2011 98
23 European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Nikolaos Dagres et al. · EP Europace Open access 18 Mar 2018 97
24 Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience Anthony Ricco, Joanne N. Davis, William R. Rate et al. · Radiation Oncology Open access 31 Jan 2017 97
25 A phase 1B dose escalation trial of Scutellaria barbata (BZL101) for patients with metastatic breast cancer Alejandra Perez, Banu Arun, Debu Tripathy et al. · Breast Cancer Research and Treatment 6 Jan 2010 93
26 Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response Kyle Wang, Panayiotis Mavroidis, Trevor Joseph Royce et al. · International Journal of Radiation Oncology*Biology*Physics Open access 22 Dec 2020 92
27 Implementing a Survivorship Care Plan for Patients With Breast Cancer Rita J. Miller · Clinical journal of oncology nursing 30 May 2008 91
28 Mesial temporal resection following long‐term ambulatory intracranial EEG monitoring with a direct brain‐responsive neurostimulation system Lawrence J. Hirsch et al. · Epilepsia Open access 18 Feb 2020 88
29 Increasing Utilization of Extended Criteria Donor Hearts for Transplantation Jacob Niall Schroder et al. · JACC Heart Failure Open access 24 Jan 2024 85
30 Full dose neoadjuvant FOLFIRINOX is associated with prolonged survival in patients with locally advanced pancreatic adenocarcinoma Moh'd M. Khushman et al. · Pancreatology 12 Sep 2015 82
31 Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib A. Oztan, Sebastian Fischer, Alexa Betzig Schrock et al. · Lung Cancer 8 Jul 2017 80
32 MCPIP1 restrains mucosal inflammation by orchestrating the intestinal monocyte to macrophage maturation via an ATF3-AP1S2 axis Huiying Lu, Cui Zhang, Wei Wu et al. · Gut 8 Sep 2022 75
33 Risk Stratification of Patients With Apparently Idiopathic Premature Ventricular Contractions Daniele Muser et al. · JACC. Clinical electrophysiology Open access 18 Dec 2019 75
34 Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets Daley S. Morera, Martin Hennig, Asif M. Talukder et al. · British Journal of Cancer Open access 3 Oct 2017 71
35 The burden of lung cancer in Latin-America and challenges in the access to genomic profiling, immunotherapy and targeted treatments Luis Estuardo Raez, Andrés Felipe Cardona, Edgardo S. Santos et al. · Lung Cancer 2 Mar 2018 68
36 ASHP Guidelines on Pharmacist Involvement in HIV Care Jason J. Schafer, Taylor K. Gill, Elizabeth M Sherman et al. · American Journal of Health-System Pharmacy 21 Mar 2016 67
37 Food Allergy Labeling Laws: International Guidelines for Residents and Travelers Francesca Chang, Lauren Eng, Christopher Chia-Chi Chang · Clinical Reviews in Allergy & Immunology Open access 9 May 2023 65
38 Phase 2 Multicenter Trial of Heterogeneous-dosing Stereotactic Body Radiotherapy for Low- and Intermediate-risk Prostate Cancer: 5-year Outcomes Donald Blake Fuller, Aaron David Falchook, Tami R. Crabtree et al. · European Urology Oncology Open access 24 Jul 2018 64
39 Statistical Comparison of Afirma Gsc and Afirma Gec Outcomes in a Community Endocrine Surgical Practice: Early Findings Richard Mack Harrell, Stephanie A. Eyerly‐Webb, Allan C. Golding et al. · Endocrine Practice Nov 2018 62
40 Molecular Targeting of the Human Epidermal Growth Factor Receptor-2 (HER2) Genes across Various Cancers Elizabeth S. Rubin, Khine Swe Shan, Shivani Dalal et al. · International Journal of Molecular Sciences Open access 15 Jan 2024 61
41 Impact of Air Pollution on Atopic Dermatitis: A Comprehensive Review Zhouxian Pan, Yimin Dai, Nicole Akar-Ghibril et al. · Clinical Reviews in Allergy & Immunology 28 Feb 2023 61
42 Genomic Landscape of Angiosarcoma: A Targeted and Immunotherapy Biomarker Analysis Andrea P. Espejo Freire, Andrew Elliott, Andrew Eric Rosenberg et al. · Cancers Open access 26 Sep 2021 61
43 Patient and Management Variables Associated With Survival After Postcardiotomy Extracorporeal Membrane Oxygenation in Adults: The PELS‐1 Multicenter Cohort Study Silvia Mariani et al. · Journal of the American Heart Association Open access 8 Jul 2023 60
44 Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer Neal D. Shore, Joseph Renzulli, Neil Eric Fleshner et al. · JAMA Oncology Open access 16 Jun 2022 60
45 Integrative Therapies in Cancer Care: An Update on the Guidelines Krisstina L. Gowin, Meri Muminovic, Suzanna Maria Zick et al. · American Society of Clinical Oncology Educational Book Open access 31 May 2024 59
46 Epidemiology, prevention, screening, diagnosis, and evaluation: update of the ICUD–SIU joint consultation on bladder cancer Mario Ignacio Fernández, Maurizio A. Brausi, Peter E. Clark et al. · World Journal of Urology 13 Aug 2018 59
47 Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature Soum D. Lokeshwar, Asif M. Talukder, Travis J. Yates et al. · Cancer Epidemiology Biomarkers & Prevention 12 Feb 2018 58
48 Tryptophan Metabolism and Its Relationship with Depression and Cognitive Impairment among HIV-infected Individuals Michael R. Keegan, Seetharamaiah Chittiprol, Scott Lee Letendre et al. · International Journal of Tryptophan Research Open access 2016 57
49 Internal Medicine Residency Program Directors’ Views of the Core Entrustable Professional Activities for Entering Residency: An Opportunity to Enhance Communication of Competency Along the Continuum Steven V. Angus, T. Robert Vu, Lisa L. Willett et al. · Academic Medicine Open access 12 Oct 2016 57
50 A randomized, phase II, dose-finding study of the pan-ErbB receptor tyrosine-kinase inhibitor CI-1033 in patients with pretreated metastatic breast cancer Olivier Rixe, Sandra Franco, Denise Aysel Yardley et al. · Cancer Chemotherapy and Pharmacology 17 Mar 2009 57

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.